Some pharmacokinetics aspects of new analgetics from hexaazaisiowuritsitane class in rats

Ksenya A. Lopatina , Olga S. Bryushinina , Roman V. Gurto , Svetlana G. Krylova , Yulia G. Zuzkova , Darya A. Kulagina , Elena A. Safonova , Elena P. Zueva , Sergey V. Sysolyatin

Reviews on Clinical Pharmacology and Drug Therapy ›› 2019, Vol. 17 ›› Issue (4) : 51 -56.

PDF
Reviews on Clinical Pharmacology and Drug Therapy ›› 2019, Vol. 17 ›› Issue (4) : 51 -56. DOI: 10.17816/RCF17451-56
Original study articles
research-article

Some pharmacokinetics aspects of new analgetics from hexaazaisiowuritsitane class in rats

Author information +
History +
PDF

Abstract

An important stage in the preclinical study of a new drug is the study of its pharmacokinetics: absorption, distribution, metabolism, and excretion of the drug compound.

The purpose of this study was to study the pharmacokinetics in healthy animals of a new analgesic based on hexaazaisowurtzitane (thiowurtzine).

Materials and methods. A technique for determining the concentration of thiowurtzine in the blood plasma and rat excreta has been developed and validated. Using high-performance liquid chromatography and tandem mass spectrometry, concentrations of thiowurtzine in plasma and rat excreta were determined after a single intragastric dose of 100 mg/kg.

Results. The peak concentration of thiowurtzine in the blood plasma of rats accounts for 2 hours, which is consistent with the pharmacodynamic data of the analgesic, the average retention time of the substance in the body reached 17.15 h after administration. Thiowurtzine is believed to be actively metabolized.

Keywords

pharmacokinetics / mass spectrometry / thiowurtzine / preclinical studies

Cite this article

Download citation ▾
Ksenya A. Lopatina, Olga S. Bryushinina, Roman V. Gurto, Svetlana G. Krylova, Yulia G. Zuzkova, Darya A. Kulagina, Elena A. Safonova, Elena P. Zueva, Sergey V. Sysolyatin. Some pharmacokinetics aspects of new analgetics from hexaazaisiowuritsitane class in rats. Reviews on Clinical Pharmacology and Drug Therapy, 2019, 17(4): 51-56 DOI:10.17816/RCF17451-56

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Мирошниченко И.И. Основы фармакокинетики. – М.: ГЭОТАР-МЕД, 2002. – 192 с. [Miroshnichenko II. Osnovy farmakokinetiki. Moscow: GEOTAR-MED; 2002. 192 p. (In Russ.)]

[2]

Руководство по проведению доклинических исследований лекарственных средств / Под ред. А.Н. Миронова. Ч. 1. – М.: Гриф и К, 2013. – 944 с. [Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv. Ed. by A.N. Mironov. Part 1. Moscow: Grief and K; 2013. 944 p. (In Russ.)]

[3]

Сергиенко В.И., Джеллифф Р., Бондарева И.Б. Прикладная фармакокинетика: основные положения и клиническое применение. – М.: Издательство РАМН, 2003. – 208 с. [Sergienko VI, Jellyff R, Bondareva IB. Prikladnaya farmakokinetika: osnovnye polozheniya i klinicheskoe primenenie. Moscow: Izdatel’stvo RAMN; 2003. 208 p. (In Russ.)]

[4]

Каркищенко Н.Н., Хоронько В.В., Сергеева С.А., Каркищенко В.Н. Фармакокинетика. – Ростов-на-Дону: Феникс, 2001. – 384 с. [Karkishchenko NN, Khoron’ko VV, Sergeeva SA, Karkishchenko VN. Farmakokinetika. Rostov-na-Donu: Phoenix; 2001. 384 p. (In Russ.)]

[5]

Лебедев А.Т. Масс-спектрометрия в органической химии. – М.: БИНОМ. Лаборатория знаний, 2003. – 493 с. [Lebedev AT. Mass-spektrometriya v organicheskoy khimii. Moscow: BINOM. Laboratoriya znaniy; 2003. 493 p. (In Russ.)]

[6]

Niessen W.M.A. MS–MS and MSn. Encyclopedia of Spectroscopy and Spectrometry. 3rd ed. Ed. by J.C. Lindon, G.E. Tranter, D. Koppenaal. Academic Press; 2016. P. 936-941.

RIGHTS & PERMISSIONS

Lopatina K.A., Bryushinina O.S., Gurto R.V., Krylova S.G., Zuzkova Y.G., Kulagina D.A., Safonova E.A., Zueva E.P., Sysolyatin S.V.

AI Summary AI Mindmap
PDF

133

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/